7
May
2024

Taizhou Dachen Pharmaceuticals Co. Ltd

Exhibitor at CPHI North America 2024 stand 1000
About Us

Established in 2017, Taizhou Dachen Pharmaceutical was designed and built to meet GMP guidelines, integrating research development and production of APIs and intermediates. The gross value of annual output is about 400 million yuan. As the National High-Tech Enterprise, the company's key products are predominantly demanded in Europe, Southeast Asia, South America, etc.


Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2023
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 1000